National Institute of Allergy and Infectious Diseases; Amended Notice of Meeting, 11282 [2016-04628]
Download as PDF
11282
Federal Register / Vol. 81, No. 42 / Thursday, March 3, 2016 / Notices
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Majed M. Hamawy, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W120,
Bethesda, MD 20892–8328, 240–276–6457,
mh101v@nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/sep/sep.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: February 29, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–04672 Filed 3–2–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR13–345:
Pediatric Formulations and Drug Delivery
Systems.
Date: March 16, 2016.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Eugene Carstea, Ph.D.,
Scientific Review Officer, Center for
VerDate Sep<11>2014
19:17 Mar 02, 2016
Jkt 238001
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194,
MSC 7846, Bethesda, MD 20892, (301) 408–
9756, carsteae@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Brain Disorders and Clinical
Neuroscience.
Date: March 23, 2016.
Time: 12:30 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Alexei Kondratyev, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5200,
MSC 7846, Bethesda, MD 20892, 301–435–
1785, kondratyevad@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Drug Abuse.
Date: March 24, 2016.
Time: 12:30 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person:
Richard D. Crosland, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 4190, MSC 7850, Bethesda, MD
20892, 301–435–1220, crosland@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 26, 2016.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–04629 Filed 3–2–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Amended Notice
of Meeting
Notice is hereby given of a change in
the meeting of the National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, March 02, 2016, 10:00
a.m. to March 02, 2016, 01:00 p.m.,
National Institutes of Health, 5601
Fishers Lane, Rockville, MD, 20892
which was published in the Federal
Register on February 09, 2016,
81FR6872.
PO 00000
Frm 00110
Fmt 4703
Sfmt 4703
This notice is being amended to
change the date of the meeting from
March 02, 2016 to March 16, 2016; and
to change the start time from 10:00 a.m.
to 1:00 p.m. and the end time from 4:00
p.m. to 6:00 p.m. The meeting is closed
to the public.
Dated: February 26, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–04628 Filed 3–2–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The review of loan
repayment applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the review
of loan repayment applications, the
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; NIAAA Clinical and
Pediatric LRP Review.
Date: April 25, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate Loan
Repayment applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 5635 Fishers Lane Rockville,
MD 20892 (Telephone Conference Call).
Contact Person: Katrina L. Foster, Ph.D.,
Scientific Review Officer, National Institute
on Alcohol Abuse & Alcoholism, National
Institutes of Health, 5635 Fishers Lane,
Room. 2019, Rockville, MD 20852, 301–443–
4032, katrina@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards., National
Institutes of Health, HHS)
E:\FR\FM\03MRN1.SGM
03MRN1
Agencies
[Federal Register Volume 81, Number 42 (Thursday, March 3, 2016)]
[Notices]
[Page 11282]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-04628]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Amended
Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Institute of Allergy and Infectious Diseases Special Emphasis Panel,
March 02, 2016, 10:00 a.m. to March 02, 2016, 01:00 p.m., National
Institutes of Health, 5601 Fishers Lane, Rockville, MD, 20892 which was
published in the Federal Register on February 09, 2016, 81FR6872.
This notice is being amended to change the date of the meeting from
March 02, 2016 to March 16, 2016; and to change the start time from
10:00 a.m. to 1:00 p.m. and the end time from 4:00 p.m. to 6:00 p.m.
The meeting is closed to the public.
Dated: February 26, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-04628 Filed 3-2-16; 8:45 am]
BILLING CODE 4140-01-P